Literature DB >> 18439062

Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.

Elena M Umland1.   

Abstract

BACKGROUND: Vasomotor symptoms (VMS), such as hot flashes and night sweats, are the most bothersome symptoms of menopause and affect an estimated 75% of women aged over 50 years.
OBJECTIVE: To discuss the burden, pathophysiology, and management of menopause-associated VMS and to evaluate pharmacologic options available for the treatment of VMS, including herbal remedies, hormone replacement therapy (HRT), and nonhormonal therapies.
SUMMARY: Lifestyle changes, including regulation of core body temperature, relaxation techniques, regular physical activity, weight loss, and smoking cessation may help reduce the risk of VMS and should be implemented by all women with menopause-associated VMS. The role of herbal remedies in the treatment of VMS remains unclear, as clinical trial efficacy data are inconsistent and inconclusive. Nevertheless, soy isoflavones, red clover isoflavones, black cohosh, and vitamin E are commonly used to treat VMS and may be considered in women with mild symptoms that are not controlled by lifestyle changes alone. These herbal remedies appear to be safe when used for short durations (d 6 months). HRT, consisting of estrogen (in women without a uterus) or estrogen plus progestin (in women with a uterus) is the most widely studied and most effective treatment option for relief of menopause-associated VMS and is considered the standard of care for women with moderate-to-severe VMS. HRT should be used at the lowest effective dose and for the shortest duration possible (preferably d 5 years) in women in whom the potential benefits outweigh the potential risks. Nonhormonal therapies, such as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, gabapentin, and clonidine, may be appropriate alternatives in women who cannot or will not use HRT for VMS relief, such as those with a history of or at risk for breast cancer.
CONCLUSION: The physical and financial burden imposed by menopauseassociated VMS is immense. Optimum management of VMS includes lifestyle changes in all women and HRT in women with moderate-tosevere symptoms. Less effective herbal remedies or nonhormonal therapies may be appropriate in certain women, such as those with mild symptoms or those who cannot or will not take HRT.

Entities:  

Mesh:

Year:  2008        PMID: 18439062     DOI: 10.18553/jmcp.2008.14.S6-A.14

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


  15 in total

Review 1.  Factors that may influence the experience of hot flushes by healthy middle-aged women.

Authors:  Ayelet Ziv-Gal; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2010-10       Impact factor: 2.681

2.  Menopausal symptoms among four major ethnic groups in the United States.

Authors:  Eun-Ok Im; Bokim Lee; Wonshik Chee; Adama Brown; Sharon Dormire
Journal:  West J Nurs Res       Date:  2010-06       Impact factor: 1.967

3.  The effect of folic Acid on menopausal hot flashes: a randomized clinical trial.

Authors:  Soheila Bani; Shirin Hasanpour; Leila Farzad Rik; Hadi Hasankhani; Seiedeh Hajar Sharami
Journal:  J Caring Sci       Date:  2013-06-01

4.  Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis.

Authors:  Tsogzolmaa Dorjgochoo; Kai Gu; Ying Zheng; Asha Kallianpur; Zhi Chen; Wei Zheng; Wei Lu; Xiao Ou Shu
Journal:  Breast Cancer Res Treat       Date:  2010-08-12       Impact factor: 4.872

5.  Psychometric evaluation of the Midlife Women's Symptom Index in multiethnic groups.

Authors:  Bokim Lee; Eun-Ok Im; Wonshik Chee
Journal:  West J Nurs Res       Date:  2010-07-06       Impact factor: 1.967

Review 6.  Weight management and its role in breast cancer rehabilitation.

Authors:  Wendy Demark-Wahnefried; Kristin L Campbell; Sandra C Hayes
Journal:  Cancer       Date:  2012-04-15       Impact factor: 6.860

7.  Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study.

Authors:  Tsogzolmaa Dorjgochoo; Kai Gu; Asha Kallianpur; Ying Zheng; Wei Zheng; Zhi Chen; Wei Lu; Xiao Ou Shu
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

8.  Use of oral contraceptives and postmenopausal hormone replacement: evidence on risk of stroke.

Authors:  Patricia H Davis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

9.  Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause.

Authors:  Jay D Amsterdam; Yubing Yao; Jun James Mao; Irene Soeller; Kenneth Rockwell; Justine Shults
Journal:  J Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.153

10.  Impact of menopausal symptoms on quality of life 6 months after systemic breast cancer treatment: results from the Shanghai Breast Cancer Survival Study.

Authors:  Tsogzolmaa Dorjgochoo; Asha Kallianpur; Ying Zheng; Kai Gu; Zhi Chen; Wei Zheng; Wei Lu; Xiao Ou Shu
Journal:  Breast Cancer Res Treat       Date:  2009-06-20       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.